// App-Quantinova.ai

: Absence of Interaction between Rivaroxaban, Tacrolimus and Everolimus in Renal Transplant Recipients Anticoagulated for Proximal Deep Vein Thrombosis or Atrial Fibrillation

Researchers

Presenter

  • G. Camporese

Principal Investigators

  • D. Bernardi

  • G.P. Avruscio

  • F. Marchini

  • E. Bernardi

  • P. Simioni

  • S. Villalta

  • M.T. Sartori

Medical Centers

  • University Hospital of Padua ‐ Unit of Angiology, Cardiac, Thoracic and Vascular Sciences, Padua, Italy

  • University Hospital of Padua, Laboratory Medicine, Padua, Italy

  • University Hospital of Padua, Nephrology and Renal Transplantation, Padua, Italy

  • Civic Hospital of Conegliano, Emergency and accident Medicine, Conegliano, Italy

  • University Hospital of Padua, Laboratory Medicine, Padua, Italy

  • Civic Hospital of Castelfranco Veneto, Internal Medicine, Castelfranco Veneto, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Deep vein thrombosis

  • Arrhythmia

  • Venous thrombosis

  • Non-valvular atrial fibrillation

Biomarkers

  • Creatinine

Drug/Treatment

  • rivaroxaban

  • Everolimus

  • Tacrolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved